Back to search

Article

Recent advances in understanding the role of glucagon-like peptide 1

2020-04-06

Abstract excerpt

The discovery that glucagon-like peptide 1 (GLP-1) mediates a significant proportion of the incretin effect during the postprandial period and the subsequent observation that GLP-1 bioactivity is retained in type 2 diabetes (T2D) led to new therapeutic strategies being developed for T2D treatment based on GLP-1 action. Although owing to its short half-life exogenous GLP-1 has no use therapeutically, GLP-1 mimetics...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
625a1895-d27b-551f-b087-ffe5ce2ed0de
DOI
10.12688/f1000research.20602.1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Recent advances in understanding the role of glucagon-like peptide 1DOI 10.12688/f1000research.20602.1
A mini review on glucagon-like peptide-1 receptor agonists and its role in blood pressure regulationSemantic proximity
Does glucagon-like peptide-1 receptor agonist therapy add value in the treatment of type 2 diabetes? Focus on exenatide.Semantic proximity
A Brief Review of Incretin Mimetics Intended for the Management of Diabetes and Associated ComorbiditiesSemantic proximity
Pathophysiology of type 2 diabetes: targeting islet cell dysfunction.Semantic proximity
The Roles of Incretin Hormones GIP and GLP-1 in Metabolic and Cardiovascular Health: A Comprehensive ReviewSemantic proximity
The pathophysiology of diabetes involves a defective amplification of the late-phase insulin response to glucose by glucose-dependent insulinotropic polypeptide-regardless of etiology and phenotype.Semantic proximity
Molecular mechanisms underlying physiological and receptor pleiotropic effects mediated by GLP ‐ 1R activationSemantic proximity
Tirzepatide as Monotherapy Improved Markers of Beta-cell Function and Insulin Sensitivity in Type 2 Diabetes (SURPASS-1)Semantic proximity
miR-204 Controls Glucagon-Like Peptide 1 Receptor Expression and Agonist Function.Semantic proximity
Effect of treatment with GLP-1R agonists on the urinary peptidome of T2DM patientsSemantic proximity
Generation and use of new tools for the characterisation of gut hormone receptorsSemantic proximity
The Cardiovascular Physiology of Glucagon-like Peptide-1 Receptor Agonists: From Macro-level Outcomes to Micro-level MechanismsSemantic proximity
Select a neighboring publication to make it the new centre.